Shanghai - Delayed Quote CNY
Qingdao Haier Biomedical Co.,Ltd (688139.SS)
31.02
+0.34
+(1.11%)
At close: 3:00:03 PM GMT+8
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,285,913.25
2,283,832.91
2,280,896.02
2,864,044.62
2,125,862.74
Cost of Revenue
1,183,249.05
1,187,914.55
1,172,339.87
1,484,880.54
1,059,841.79
Gross Profit
1,102,664.20
1,095,918.36
1,108,556.15
1,379,164.08
1,066,020.94
Operating Expense
784,002.49
752,550.49
773,116.16
784,638.55
602,481.20
Operating Income
318,661.72
343,367.86
335,439.99
594,525.53
463,539.74
Net Non Operating Interest Income Expense
36,814.05
42,793.17
31,256.55
16,698.68
7,740.06
Pretax Income
372,745.19
401,956.70
434,491.21
675,336.08
960,871.17
Tax Provision
17,391.42
20,948.66
22,432.55
63,362.05
111,700.77
Net Income Common Stockholders
339,276.34
366,632.80
406,073.64
600,791.26
845,035.31
Basic EPS
1.07
1.16
1.28
1.89
2.67
Diluted EPS
1.07
1.16
1.28
1.89
2.66
Basic Average Shares
316,628.47
316,062.76
317,245.03
317,878.98
316,492.62
Diluted Average Shares
316,628.47
316,062.76
317,245.03
317,878.98
317,682.45
Total Operating Income as Reported
374,097.36
401,827.81
438,401.34
675,680.19
961,433.98
Rent Expense Supplemental
--
--
--
--
4,081.67
Total Expenses
1,967,251.53
1,940,465.05
1,945,456.03
2,269,519.09
1,662,323
Net Income from Continuing & Discontinued Operation
339,276.34
366,632.80
406,073.64
600,791.26
845,035.31
Normalized Income
352,502.67
378,565.81
409,492.09
613,338.42
833,772.26
Interest Income
43,395.34
47,662.11
35,609.32
20,299.60
10,682.87
Interest Expense
3,544.56
3,410.32
3,511.62
2,685.01
2,891.96
Net Interest Income
36,814.05
42,793.17
31,256.55
16,698.68
7,740.06
EBIT
376,289.75
405,367.02
438,002.83
678,021.09
963,763.13
EBITDA
376,289.75
525,901.67
541,445.35
742,202.57
1,014,715.59
Reconciled Cost of Revenue
1,183,249.05
1,187,914.55
1,172,339.87
1,484,880.54
1,059,841.79
Reconciled Depreciation
--
120,534.65
103,442.52
64,181.48
50,952.46
Net Income from Continuing Operation Net Minority Interest
339,276.34
366,632.80
406,073.64
600,791.26
845,035.31
Total Unusual Items Excluding Goodwill
-13,873.64
-12,589.12
-3,604.55
-13,846.25
12,744.60
Total Unusual Items
-13,873.64
-12,589.12
-3,604.55
-13,846.25
12,744.60
Normalized EBITDA
390,163.40
538,490.79
545,049.89
756,048.83
1,001,970.99
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-647.31
-656.10
-186.10
-1,299.10
1,481.55
12/31/2021 - 10/25/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
Upgrade